However, in the ovarian cancer survival data from the PrognoScan dataset (n = 1656), we found that the OS in MYL5 high-expression group was shorter than the MYL5 low-expression group, which contained to the analysis of survival data from the Kaplan–Meier plotter dataset (n = 123) (Figure 3(p)), and we speculated that the contradictory results could be caused by the number of samples. The gene discussed is MYL5; the disease is ovarian carcinoma.